HIGHLIGHTS
- who: Maurice T. Driessen from the (UNIVERSITY) have published the research work: Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study, in the Journal: (JOURNAL) of September/14,/2018
- what: The study showed substantial and sustained improvements, after either quarterly or monthly fremanezumab treatment, in MMD, MHD, and HIT-6 and MIDAS scores in a population with migraine, most of whom had previously failed u2265 2 migraine preventive treatments.
- how: Patient characteristics and effectiveness and disability outcomes were evaluated in the patient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.